REGISTRAT-MAPI & Trianz Collaborate on Developing Acceliant EDC Platform’s ePRO Capabilities

HERNDON, Va., Oct. 13 /PRNewswire/ -- Trianz Business Solutions is pleased to announce that REGISTRAT-MAPI, a long term client of Acceliant eClinical suite, has agreed to serve as advisors in the development of the ePRO/mPRO module for Acceliant. REGISTRAT-MAPI has utilized Acceliant since 2007, for many of their Late Phase studies. REGISTRAT-MAPI, using their clinical experience and knowledge of the industry accumulated conducting Late Phase studies, will advise Trianz in defining and reviewing the ePRO module.

Stephen Webb, REGISTRAT-MAPI, President North America stated that, "since the majority of our late phase studies include collecting, analyzing and interpreting patient reported outcome (PRO) data to demonstrate product effectiveness and evidence based science, having these robust ePRO tools and web-based applications significantly contribute to successful conduct of these studies."

Acceliant V6.1, released earlier this year, and V6.2 scheduled for Q4 2010 release, already incorporates a number of functional enhancements identified by REGISTRAT-MAPI based on their unique PRO experience as the leading Global Late Phase CRO dedicated to 'real life' clinical research. Trianz and REGISTRAT-MAPI greatly value this mutually benefitted collaboration. The Acceliant ePRO module seamlessly integrates with the Acceliant eClinical Suite to expand the breadth of data collection channels and technology options.

Sri Manchala, President and CEO of Trianz, adds, "Acceliant ePRO supports a rich set of features for patients to register, enroll and complete the necessary forms. Data capture applications include: Web, Smart Phones, Tablets, and IVRS. Additionally, the ePRO module provides sites with patient profiles, custom reports and real-time access to data." Trianz will be demonstrating an initial version of the Acceliant ePRO module at the 2010 Annual Meeting of the Society for Clinical Data Management (SCDM) in Minneapolis, MN.

About REGISTRAT-MAPI

REGISTRAT-MAPI, the industry's largest leading global clinical research organization (CRO) dedicated solely to 'real life' late phase clinical research, has extensive experience in the design, implementation and management of pre- and post-approval studies for biopharmaceutical and medical device clients. Our recent experience includes successful studies that reach into more than 32 countries. REGISTRAT-MAPI provides integrated clinical development services worldwide with offices in: Philadelphia, PA; Lexington, KY; Paris and Lyon, France; Rome, Italy; London, England; Utrecht, Netherlands; and Frankfurt, Germany. Visit http://www.registratmapi.com.

About Trianz Business Solutions

For over a decade, Trianz Solutions (http://solutions.trianz.com/) has been providing Fortune 1000 clients with innovative software platforms and associated professional services to be competitive in meeting the challenges of today's dynamic market conditions. The Acceliant eClinical Suite is its pre-eminent offering that continues its 10-year history of providing innovative solutions for the Life Sciences industry.

Trianz Solutions is a division of Trianz (http://www.trianz.com), a client-oriented organization that provides an integrated set of Consulting, IT and BPO solutions, each enabled by innovative and proprietary global execution model. Trianz firmly believes that the flawless execution of business, technology and operational initiatives is a key ingredient of business success. And our mission is to partner with business leaders, who share the belief that Execution Matters. We understand top management's vision and objectives which visualize business results and translate these to the execution of strategy using relevant technology and process outsourcing.

SOURCE Trianz